Titelia

Fund shareholders of Tenax Therapeutics Inc

ISIN US88032L6056 · United States · LEI 549300J03O6B1IJ2B606

Fund shareholders
24
Of which ETFs
5 19 other funds
Value held
53.5M $
Share of capital
9.2 % of 37.4M shares on Jul 28, 2026
FundSharesValueWeight in fundShare of capital
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. 2,481,06639.7M $0.36 %6.63 %as of Mar 31, 2026 ↗
Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII 322,6004.2M $0.22 %0.86 %as of Apr 30, 2026 ↗
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 194,1593.1M $0.00 %0.52 %as of Mar 31, 2026 ↗
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. 151,4502.4M $0.37 %0.40 %as of Mar 31, 2026 ↗
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 64,1861M $0.00 %0.17 %as of Mar 31, 2026 ↗
Dimensional U.S. Small Cap ETF Dimensional ETF Trust 59,318777.7K $0.01 %0.16 %as of Apr 30, 2026 ↗
Ultra-Small Company Fund Bridgeway Funds, Inc. 44,900718K $0.84 %0.12 %as of Mar 31, 2026 ↗
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 28,603343.2K $0.00 %0.08 %as of Feb 28, 2026 ↗
U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 23,428307.1K $0.00 %0.06 %as of Apr 30, 2026 ↗
Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust 13,785180.7K $0.00 %0.04 %as of Apr 30, 2026 ↗
U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 12,694166.4K $0.00 %0.03 %as of Apr 30, 2026 ↗
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 9,924119.1K $0.00 %0.03 %as of Feb 28, 2026 ↗
Fidelity Total Market Index Fund Fidelity Concord Street Trust 8,940107.3K $0.00 %0.02 %as of Feb 28, 2026 ↗
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS 5,07681.2K $0.00 %0.01 %as of Mar 31, 2026 ↗
U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 2,83537.2K $0.00 %0.01 %as of Apr 30, 2026 ↗
U.S. Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 2,75136.1K $0.00 %0.01 %as of Apr 30, 2026 ↗
Dimensional US Core Equity Market ETF Dimensional ETF Trust 2,25129.5K $0.00 %0.01 %as of Apr 30, 2026 ↗
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 2,05124.6K $0.00 %0.01 %as of Feb 28, 2026 ↗
JNL/DFA U.S. Small Cap Fund JNL Series Trust 1,64426.3K $0.00 %0.00 %as of Mar 31, 2026 ↗
T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. 1,51624.2K $0.16 %0.00 %as of Mar 31, 2026 ↗
Health Sciences Trust John Hancock Variable Insurance Trust 1,20219.2K $0.01 %0.00 %as of Mar 31, 2026 ↗
U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 1,09014.3K $0.00 %as of Apr 30, 2026 ↗
Dimensional US Core Equity 1 ETF Dimensional ETF Trust 94912.4K $0.00 %0.00 %as of Apr 30, 2026 ↗
EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust 84213.5K $0.01 %0.00 %as of Mar 31, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Ultra-Small Company Fund Bridgeway Funds, Inc. 0.84 %as of Mar 31, 2026 ↗
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. 0.37 %as of Mar 31, 2026 ↗
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. 0.36 %as of Mar 31, 2026 ↗
Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII 0.22 %as of Apr 30, 2026 ↗
T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. 0.16 %as of Mar 31, 2026 ↗
EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust 0.01 %as of Mar 31, 2026 ↗
Health Sciences Trust John Hancock Variable Insurance Trust 0.01 %as of Mar 31, 2026 ↗
Dimensional U.S. Small Cap ETF Dimensional ETF Trust 0.01 %as of Apr 30, 2026 ↗
U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗
JNL/DFA U.S. Small Cap Fund JNL Series Trust 0.00 %as of Mar 31, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q224+113,437,260+448.7 %
2026Q113+5626,424+249.6 %
2025Q48+1179,183+165.3 %
2025Q37067,532+14.7 %
2025Q27058,886-5.8 %
2025Q17+162,511+3.0 %
2024Q46+360,676+1,357.5 %
2024Q33-14,163-0.3 %
2024Q244,176

Institutional managers

75 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
PRICE T ROWE ASSOCIATES INC /MD/2,951,11647.2K $as of Mar 31, 2026
JANUS HENDERSON GROUP PLC1,815,47429.1M $as of Mar 31, 2026
Venrock Adviser, LLC1,675,26226.8M $as of Mar 31, 2026
PERCEPTIVE ADVISORS LLC1,447,78223.2M $as of Mar 31, 2026
Ikarian Capital, LLC1,017,60016.3M $as of Mar 31, 2026
Stonepine Capital Management, LLC975,20015.6M $as of Mar 31, 2026
Logos Global Management LP625,00010M $as of Mar 31, 2026
MORGAN STANLEY596,5649.5M $as of Mar 31, 2026
Velan Capital Investment Management LP583,3339.3M $as of Mar 31, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.540,1268.6M $as of Mar 31, 2026
Point72 Asset Management, L.P.533,9658.5M $as of Mar 31, 2026
MILLENNIUM MANAGEMENT LLC533,8898.5M $as of Mar 31, 2026
ARMISTICE CAPITAL, LLC478,8277.7M $as of Mar 31, 2026
Siren, L.L.C.427,1416.8M $as of Mar 31, 2026
TD Asset Management Inc399,1846.4M $as of Mar 31, 2026
UBS Group AG381,4196.1M $as of Mar 31, 2026
RTW INVESTMENTS, LP370,2465.9M $as of Mar 31, 2026
BOOTHBAY FUND MANAGEMENT, LLC366,7915.9M $as of Mar 31, 2026
MARSHALL WACE, LLP352,5725.6M $as of Mar 31, 2026
BVF INC/IL339,5495.4M $as of Mar 31, 2026
GREAT POINT PARTNERS LLC327,3075.2M $as of Mar 31, 2026
Woodline Partners LP323,9115.2M $as of Mar 31, 2026
FMR LLC322,6005.2M $as of Mar 31, 2026
AMERIPRISE FINANCIAL INC279,5374.5M $as of Mar 31, 2026
Avidity Partners Management LP215,9343.5M $as of Mar 31, 2026

Declared shareholders of Tenax Therapeutics Inc

There are 15 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
BIOTECHNOLOGY VALUE FUND L P and 9 others9.99 %1,908,722as of Mar 31, 2026 · SCHEDULE 13G
RTW Investments, LP and 1 other9.90 %1,867,630as of Mar 31, 2026 · SCHEDULE 13G
Venrock Healthcare Capital Partners III, L.P. and 6 others9.90 %1,955,105as of Mar 31, 2026 · SCHEDULE 13G
Ikarian Capital, LLC and 1 other6.70 %1,145,100as of Mar 31, 2026 · SCHEDULE 13G
Perceptive Advisors LLC and 2 others5.50 %1,447,782as of Mar 31, 2026 · SCHEDULE 13G
Millennium Management LLC and 2 others5.10 %1,347,130as of May 18, 2026 · SCHEDULE 13G
Stonepine Capital Management, LLC and 3 others3.70 %975,200as of Mar 31, 2026 · SCHEDULE 13G
Morgan Stanley and 1 other3.50 %596,564as of Mar 31, 2026 · SCHEDULE 13G
Point72 Asset Management, L.P. and 2 others3.10 %533,965as of Mar 31, 2026 · SCHEDULE 13G
Logos Global Management LP and 4 others3.00 %800,000as of Mar 31, 2026 · SCHEDULE 13G
Invus Public Equities, L.P. and 7 others2.50 %427,141as of Mar 31, 2026 · SCHEDULE 13G
Dellora Investments Master Fund LP and 2 others2.30 %394,665as of May 15, 2026 · SCHEDULE 13G
T. Rowe Price Associates, Inc. 2.20 %586,990as of May 31, 2026 · SCHEDULE 13G
Integrated Core Strategies (US) LLC and 3 others2.10 %533,889as of Mar 31, 2026 · SCHEDULE 13G
Lind Global Fund II LP and 2 others0.78 %202,480as of Mar 31, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Fund shareholders of Tenax Therapeutics Inc". https://titelia.com/en/stocks/tenax-therapeutics-inc-US88032L6056